TS 091
Alternative Names: TS 0911; TS091Latest Information Update: 24 Oct 2021
Price :
$50 *
At a glance
- Originator Taisho Pharmaceutical
- Class Sleep disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypersomnia; Narcolepsy